Seven findings from the KRAS research record

Computed from 196 clinical trials, 2,970 papers and 452 NIH grants as the records stand on 2 Nov 2026. Hover a figure for its values, click a trial or paper to open the record, or ask a follow-up question.

Trial starts peaked in 2026, with 32 of the 193 KRAS trials in the record.

Phase 1Phase 2Phase 3Phase not stated

41 of 158 KRAS trials are immunotherapy & vaccines.

69 of 193 trials are recruiting patients now; 22 have posted results.

RecruitingNot yet recruitingStopped early

The 40 most recent starts are shown; 153 earlier trials are left off.

11 trials account for 52% of the 4,826 places where patients can enroll; 79 of 196 run at one site or have none listed yet.

RecruitingActive, not recruitingCompletedOther status

1,861 of the 3,922 research places in the record are in the United States; The University of Texas MD Anderson Cancer Center hosts the most trials, 49.

1,909 places on this map

The University of Texas MD Anderson Cancer Center167
Memorial Sloan Kettering Cancer Center75
Johns Hopkins University69
University of North Carolina at Chapel Hill68
Mayo Clinic61
University of Michigan54
University of California, Los Angeles41
Dana-Farber Cancer Institute38
University of California, San Francisco37

Outside this map: 263 in China, 173 in France, 173 in Italy, 164 in Germany, 159 in Spain, 121 in Japan, 97 in United Kingdom, 92 in Australia, 79 in AT, 73 in South Korea, 66 in BE, 52 in PL, 43 in Netherlands, 42 in TW, 40 in BR, 25 in IN, 24 in RU, 24 in HU, 23 in CZ, 22 in IL, 21 in CH, 20 in PT, 19 in SG, 17 in Denmark, 15 in MX, 14 in RO, 13 in GR, 11 in NO, 10 in SE, 10 in United States, 10 in PR, 9 in IE, 9 in HK, 9 in GEORGIA, 9 in FI, 5 in TR, 5 in IR, 4 in MY, 4 in TH, 4 in RS, 4 in NZ, 3 in SA, 2 in HR, 2 in JO, 2 in PK, 2 in LB, 2 in UA, 1 in CL, 1 in EG, 1 in IQ, 1 in AR, 1 in SI, 1 in LT, 1 in ZA, 1 in NG, 1 in MO, 1 in KW, 1 in AE, 1 in BN, 1 in TN, 1 in AF, 1 in CO, 1 in ID, 1 in QA.

KRAS saw papers or trials in 16 years and NIH money in 16; they coincide in 16.

Papers or trials, no NIH dollarsNIH dollars, no papers or trialsBoth

Each square is one topic in one year. Blue years produced work with no new NIH money behind it; amber years were funded but produced no paper or trial that year.

Grants pay out over several years and results lag funding, so a gap here is a question to ask, not a verdict. Switch the view to see dollars or output alone.

Source: NIH RePORTER (National Institutes of Health, NIAAA, NIA, NIAID, NIAMS, NCCIH, NCI (intramural), NIH BX, NCI, NIH Clinical Center, NIH CP, NIH CX, NIDCR, NIDDK, NIBIB, NIEHS, NEI, NIH FD, NIGMS, NICHD, NHGRI, NHLBI, NIH HX, NLM, NIMHD, NIMH, NINDS, NIH OD, NIH RD, NCRR, NCI (intramural), NCATS, FIC, Congressionally Directed Medical Research Programs - Pancreatic Cancer Research Program, Lustgarten Foundation, Pancreatic Cancer Action Network) against Europe PMC papers and ClinicalTrials.gov starts.

Ask about this →